FLASH
Shkruar nga Pamfleti
A new cosmetic treatment is attracting attention in the US, but it's also causing controversy. It's alloClae, a product that uses processed human fat tissue to restore volume to various areas of the body.
Unlike classic interventions that use the patient's own fat, this method relies on tissue taken from donors, which is processed in the laboratory before being used. According to the company that produces it, the material undergoes a special process to eliminate the donor's cellular elements and make it suitable for aesthetic use.
The product became available in the US market in 2024 and was initially applied only by plastic surgeons. Later, its use was extended to other trained professionals. The company claims that thousands of people have undergone treatments with this technology.
Why is interest in this procedure growing?
One factor that has influenced the demand for such treatments is the increase in the use of weight loss medications. After rapid weight loss, some people seek to restore volume to the face, chest or other areas of the body.
For this reason, alloClae is being presented as a faster solution compared to procedures where fat is taken from the patient themselves.
Doctors are asking for more evidence
Despite the great interest, the medical community remains divided. Some specialists warn that there are still not enough studies to assess long-term outcomes.
Among the concerns raised are complications such as damage to the injected tissue, the formation of granules under the skin, pain, or changes in the appearance of the treated area.
The manufacturer insists that no confirmed cases of rejection or infections have been reported so far, but some surgeons prefer to wait for more data before widely incorporating it into their practice.
The clash between medicine and ethics
In addition to scientific questions, the method has also raised moral debate. Critics raise concerns that using human tissue for profitable cosmetic products could violate the spirit of donation.
Bioethics experts have questioned whether donors and their families had a full understanding of how these tissues might be used.
Europe remains more cautious
In some European countries, specialists are more skeptical of this approach. They point out that fat is a complex biological material and that it has not yet been fully proven whether tissue from another person can give the same results as fat taken from the patient's own body.
As the aesthetic industry continues to seek new alternatives, alloClae has become one of the most discussed examples of the clash between medical innovation, the desire for physical change, and ethical boundaries.
Lini një Përgjigje